Lackland, DT; Weber, MA (maio de 2015). «Global burden of cardiovascular disease and stroke: hypertension at the core.». The Canadian journal of cardiology. 31 (5): 569–71. PMID25795106. doi:10.1016/j.cjca.2015.01.009
Hernandorena, I; Duron, E; Vidal, JS; Hanon, O (julho de 2017). «Treatment options and considerations for hypertensive patients to prevent dementia». Expert Opinion on Pharmacotherapy (Review). 18 (10): 989-1000. PMID28532183. doi:10.1080/14656566.2017
Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.; Casey, Donald E.; Collins, Karen J.; Dennison Himmelfarb, Cheryl; DePalma, Sondra M.; Gidding, Samuel; Jamerson, Kenneth A.; Jones, Daniel W.; MacLaughlin, Eric J.; Muntner, Paul; Ovbiagele, Bruce; Smith, Sidney C.; Spencer, Crystal C.; Stafford, Randall S.; Taler, Sandra J.; Thomas, Randal J.; Williams, Kim A.; Williamson, Jeff D.; Wright, Jackson T. (13 de novembro de 2017). «2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults». Hypertension: HYP.0000000000000065. doi:10.1161/HYP.0000000000000065
Campbell, NR; Lackland, DT; Lisheng, L; Niebylski, ML; Nilsson, PM; Zhang, XH (março de 2015). «Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League.». Journal of clinical hypertension (Greenwich, Conn.). 17 (3): 165–67. PMID25644474. doi:10.1111/jch.12479
Giuseppe, Mancia; Fagard, R; Narkiewicz, K; Redon, J; Zanchetti, A; Bohm, M; Christiaens, T; Cifkova, R; De Backer, G; Dominiczak, A; Galderisi, M; Grobbee, DE; Jaarsma, T; Kirchhof, P; Kjeldsen, SE; Laurent, S; Manolis, AJ; Nilsson, PM; Ruilope, LM; Schmieder, RE; Sirnes, PA; Sleight, P; Viigimaa, M; Waeber, B; Zannad, F; Redon, J; Dominiczak, A; Narkiewicz, K; Nilsson, PM; et al. (julho de 2013). «2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)». European Heart Journal. 34 (28): 2159–219. PMID23771844. doi:10.1093/eurheartj/eht151
James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; et al. (dezembro de 2013). «2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)». JAMA. 311 (5): 507–20. PMID24352797. doi:10.1001/jama.2013.284427
Musini, VM; Tejani, AM; Bassett, K; Wright, JM (7 de outubro de 2009). «Pharmacotherapy for hypertension in the elderly.». The Cochrane database of systematic reviews (4): CD000028. PMID19821263. doi:10.1002/14651858.CD000028.pub2
Sundström, Johan; Arima, Hisatomi; Jackson, Rod; Turnbull, Fiona; Rahimi, Kazem; Chalmers, John; Woodward, Mark; Neal, Bruce (fevereiro de 2015). «Effects of Blood Pressure Reduction in Mild Hypertension». Annals of Internal Medicine. 162: 184–91. PMID25531552. doi:10.7326/M14-0773
Xie, X; Atkins, E; Lv, J; Bennett, A; Neal, B; Ninomiya, T; Woodward, M; MacMahon, S; Turnbull, F; Hillis, GS; Chalmers, J; Mant, J; Salam, A; Rahimi, K; Perkovic, V; Rodgers, A (30 de janeiro de 2016). «Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.». Lancet. 387 (10017): 435–43. PMID26559744. doi:10.1016/S0140-6736(15)00805-3
Diao, D; Wright, JM; Cundiff, DK; Gueyffier, F (15 de agosto de 2012). «Pharmacotherapy for mild hypertension.». The Cochrane database of systematic reviews. 8: CD006742. PMID22895954. doi:10.1002/14651858.CD006742.pub2
Garrison, SR; Kolber, MR; Korownyk, CS; McCracken, RK; Heran, BS; Allan, GM (8 de agosto de 2017). «Blood pressure targets for hypertension in older adults.». The Cochrane database of systematic reviews. 8: CD011575. PMID28787537. doi:10.1002/14651858.CD011575.pub2
Musini, VM; Gueyffier, F; Puil, L; Salzwedel, DM; Wright, JM (16 de agosto de 2017). «Pharmacotherapy for hypertension in adults aged 18 to 59 years.». The Cochrane database of systematic reviews. 8: CD008276. PMID28813123. doi:10.1002/14651858.CD008276.pub2
G., Mancia; De Backer G, Dominiczak A, Renata Cifkova, Robert Fagard, Giuseppe Germano, Guido Grassi, Anthony M Heagerty, Sverre E Kjeldsen (setembro de 2007). «2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension». J. Hypertens. (em inglês). 25 (9): 1751–62. PMID17762635. doi:10.1097/HJH.0b013e3282f0580f|acessodata= requer |url= (ajuda) !CS1 manut: Nomes múltiplos: lista de autores (link)
Williams, B; Poulter NR; Brown MJ; Davis M; et al. (Março de 2004). «Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV». Journal of Human Hypertension (em inglês). 18 (3): 139-85. PMID14973512. doi:10.1038/sj.jhh.1001683
Mancia G et.al (2007). «2007 Guidelines for the Management of Arterial Hypertension - The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the EuropeanSociety of Cardiology.». Eur Heart J. 28 (12): 1462–1536. PMID17562668. doi:10.1093/eurheartj/ehm236
Dionne, JM; Abitbol CL, Flynn JT (Janeiro de 2012). «Hypertension in infancy: diagnosis, management and outcome.». Pediatric Nephrology (em inglês). 27 (1): 17–32. PMID21258818. doi:10.1007/s00467-010-1755-z
Papadopoulos, DP; Mourouzis I; Thomopoulos C; Makris T; et al. (Dezembro de 2010). «Hypertension crisis». Blood Press. (em inglês). 19 (6): 328–36. PMID20504242. doi:10.3109/08037051.2010.488052
He, FJ; MacGregor GA (Junho de 2009). «A comprehensive review on salt and health and current experience of worldwide salt reduction programmes». Journal of Human Hypertension (em inglês). 23 (6): 363–84. PMID19110538. doi:10.1038/jhh.2008.144
Lawlor, Debbie A; Smith, GD (Maio de 2005). «Early life determinants of adult blood pressure.». Current Opinion in Nephrology & Hypertension (em inglês). 14 (3): 259–64. PMID15821420. doi:10.1097/01.mnh.0000165893.13620.2b
Grossman, Ehud; Messerli FH (Janeiro de 2012). «Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension». Am. J. Med. (em inglês). 125 (1): 14–22. PMID22195528. doi:10.1016/j.amjmed.2011.05.024
Palatini, Paolo; Julius S (Junho de 2009). «The role of cardiac autonomic function in hypertension and cardiovascular disease.». Current Hypertension Reports (em inglês). 11 (3): 199-205. PMID19442329. doi:10.1007/s11906-009-0035-4
Andersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR (2004). «Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study». Blood Press. 13 (6): 350–4. PMID15771219. doi:10.1080/08037050410004819 !CS1 manut: Nomes múltiplos: lista de autores (link)
Chobanian AV (agosto de 2007). «Clinical practice. Isolated systolic hypertension in the elderly». N. Engl. J. Med. 357 (8): 789–96. PMID17715411. doi:10.1056/NEJMcp071137
Whelton, PK; He J, Appel LJ, Cutler JA; et al. (Outubro de 2002). «Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program». JAMA (em inglês). 288 (15): 1882-8. PMID12377087. doi:10.1001/jama.288.15.1882 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Siebenhofer, Andrea; Jeitler K, Berghold A, Waltering A; et al. (7 de setembro de 2011). «Long-term effects of weight-reducing diets in hypertensive patients». Cochrane Database Syst Rev. (em inglês) (9): CD008274. PMID21901719. doi:10.1002/14651858.CD008274.pub !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Blumenthal, JA; Babyak MA; Hinderliter A; Watkins LL; et al. (Janeiro de 2010). «Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study.». Arch Intern Med (em inglês). 170 (2): 126-35. PMID20101007. doi:10.1001/archinternmed.2009.470
Greenhalgh, J; Dickson R, Dundar Y (Outubro de 2009). «The effects of biofeedback for the treatment of essential hypertension: a systematic review.». Health Technol Assess. (em inglês). 13 (46): 1-104. PMID19822104. doi:10.3310/hta13460
He, Feng J; MacGregor GA (2004). «Effect of longer-term modest salt reduction on blood pressure». Cochrane Database Syst Rev. (em inglês) (3): CD004937. PMID15266549. doi:10.1002/14651858.CD004937
Musini, Vijaya M; Tejani AM, Bassett K, Wright JM (2009). «Pharmacotherapy for hypertension in the elderly». Cochrane Database Syst Rev (em inglês) (4): CD000028. PMID19821263. doi:10.1002/14651858.CD000028.pub2 !CS1 manut: Nomes múltiplos: lista de autores (link)
Calhoun DA; Jones D; Textor S; et al. (Junho de 2008). «Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research». Hypertension. 51 (6): 1403–19. PMID18391085. doi:10.1161/HYPERTENSIONAHA.108.189141
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (Dezembro de 2002). «Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies». Lancet. 360 (9349): 1903–13. PMID12493255. doi:10.1016/S0140-6736(02)11911-8 !CS1 manut: Nomes múltiplos: lista de autores (link)
Singer DR, Kite A (Junho de 2008). «Management of hypertension in peripheral arterial disease: does the choice of drugs matter?». European Journal of Vascular and Endovascular Surgery. 35 (6): 701–8. PMID18375152. doi:10.1016/j.ejvs.2008.01.007
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (abril de 2009). «Reactive oxygen species and dopamine receptor function in essential hypertension». Clinical and Experimental Hypertension. 31 (2): 156–78. PMID19330604. doi:10.1080/10641960802621283 !CS1 manut: Nomes múltiplos: lista de autores (link)
Kearney, PM; Whelton M, Reynolds K, Muntner P; et al. (Janeiro de 2005). «Global burden of hypertension: analysis of worldwide data». Lancet (em inglês). 365 (9455): 217–23. PMID15652604. doi:10.1016/S0140-6736(05)17741-1 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Alcocer, L; Cueto L (Junho de 2008). «Hypertension, a health economics perspective». Therapeutic Advances in Cardiovascular Disease (em inglês). 2 (3): 147-55. PMID19124418. doi:10.1177/1753944708090572
Elliott, William J (Outubro de 2003). «The Economic Impact of Hypertension». The Journal of Clinical Hypertension (em inglês). 5 (4): 3-13. PMID12826765. doi:10.1111/j.1524-6175.2003.02463.x
Coca, A (2008). «Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)». Clinical Drug Investigation (em inglês). 28 (4): 211-20. PMID18345711. doi:10.2165/00044011-200828040-00002
National Clinical Guidance Centre (Agosto de 2011). «7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations». Hypertension (NICE CG 127)(PDF). [S.l.]: National Institute for Health and Clinical Excellence. p. 102. Consultado em 22 de dezembro de 2012. Arquivado do original(PDF) em 23 de julho de 2013
North of England Hypertension Guideline Development Group (1 de agosto de 2004). «Frequency of measurements». Essential hypertension (NICE CG18). [S.l.]: National Institute for Health and Clinical Excellence. p. 53. Consultado em 6 de janeiro de 2013
nih.gov
ncbi.nlm.nih.gov
Lackland, DT; Weber, MA (maio de 2015). «Global burden of cardiovascular disease and stroke: hypertension at the core.». The Canadian journal of cardiology. 31 (5): 569–71. PMID25795106. doi:10.1016/j.cjca.2015.01.009
Hernandorena, I; Duron, E; Vidal, JS; Hanon, O (julho de 2017). «Treatment options and considerations for hypertensive patients to prevent dementia». Expert Opinion on Pharmacotherapy (Review). 18 (10): 989-1000. PMID28532183. doi:10.1080/14656566.2017
Campbell, NR; Lackland, DT; Lisheng, L; Niebylski, ML; Nilsson, PM; Zhang, XH (março de 2015). «Using the Global Burden of Disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League.». Journal of clinical hypertension (Greenwich, Conn.). 17 (3): 165–67. PMID25644474. doi:10.1111/jch.12479
Giuseppe, Mancia; Fagard, R; Narkiewicz, K; Redon, J; Zanchetti, A; Bohm, M; Christiaens, T; Cifkova, R; De Backer, G; Dominiczak, A; Galderisi, M; Grobbee, DE; Jaarsma, T; Kirchhof, P; Kjeldsen, SE; Laurent, S; Manolis, AJ; Nilsson, PM; Ruilope, LM; Schmieder, RE; Sirnes, PA; Sleight, P; Viigimaa, M; Waeber, B; Zannad, F; Redon, J; Dominiczak, A; Narkiewicz, K; Nilsson, PM; et al. (julho de 2013). «2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)». European Heart Journal. 34 (28): 2159–219. PMID23771844. doi:10.1093/eurheartj/eht151
James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; et al. (dezembro de 2013). «2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)». JAMA. 311 (5): 507–20. PMID24352797. doi:10.1001/jama.2013.284427
Musini, VM; Tejani, AM; Bassett, K; Wright, JM (7 de outubro de 2009). «Pharmacotherapy for hypertension in the elderly.». The Cochrane database of systematic reviews (4): CD000028. PMID19821263. doi:10.1002/14651858.CD000028.pub2
Sundström, Johan; Arima, Hisatomi; Jackson, Rod; Turnbull, Fiona; Rahimi, Kazem; Chalmers, John; Woodward, Mark; Neal, Bruce (fevereiro de 2015). «Effects of Blood Pressure Reduction in Mild Hypertension». Annals of Internal Medicine. 162: 184–91. PMID25531552. doi:10.7326/M14-0773
Xie, X; Atkins, E; Lv, J; Bennett, A; Neal, B; Ninomiya, T; Woodward, M; MacMahon, S; Turnbull, F; Hillis, GS; Chalmers, J; Mant, J; Salam, A; Rahimi, K; Perkovic, V; Rodgers, A (30 de janeiro de 2016). «Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.». Lancet. 387 (10017): 435–43. PMID26559744. doi:10.1016/S0140-6736(15)00805-3
Diao, D; Wright, JM; Cundiff, DK; Gueyffier, F (15 de agosto de 2012). «Pharmacotherapy for mild hypertension.». The Cochrane database of systematic reviews. 8: CD006742. PMID22895954. doi:10.1002/14651858.CD006742.pub2
Garrison, SR; Kolber, MR; Korownyk, CS; McCracken, RK; Heran, BS; Allan, GM (8 de agosto de 2017). «Blood pressure targets for hypertension in older adults.». The Cochrane database of systematic reviews. 8: CD011575. PMID28787537. doi:10.1002/14651858.CD011575.pub2
Musini, VM; Gueyffier, F; Puil, L; Salzwedel, DM; Wright, JM (16 de agosto de 2017). «Pharmacotherapy for hypertension in adults aged 18 to 59 years.». The Cochrane database of systematic reviews. 8: CD008276. PMID28813123. doi:10.1002/14651858.CD008276.pub2
G., Mancia; De Backer G, Dominiczak A, Renata Cifkova, Robert Fagard, Giuseppe Germano, Guido Grassi, Anthony M Heagerty, Sverre E Kjeldsen (setembro de 2007). «2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension». J. Hypertens. (em inglês). 25 (9): 1751–62. PMID17762635. doi:10.1097/HJH.0b013e3282f0580f|acessodata= requer |url= (ajuda) !CS1 manut: Nomes múltiplos: lista de autores (link)
Williams, B; Poulter NR; Brown MJ; Davis M; et al. (Março de 2004). «Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV». Journal of Human Hypertension (em inglês). 18 (3): 139-85. PMID14973512. doi:10.1038/sj.jhh.1001683
Mancia G et.al (2007). «2007 Guidelines for the Management of Arterial Hypertension - The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the EuropeanSociety of Cardiology.». Eur Heart J. 28 (12): 1462–1536. PMID17562668. doi:10.1093/eurheartj/ehm236
Dionne, JM; Abitbol CL, Flynn JT (Janeiro de 2012). «Hypertension in infancy: diagnosis, management and outcome.». Pediatric Nephrology (em inglês). 27 (1): 17–32. PMID21258818. doi:10.1007/s00467-010-1755-z
Papadopoulos, DP; Mourouzis I; Thomopoulos C; Makris T; et al. (Dezembro de 2010). «Hypertension crisis». Blood Press. (em inglês). 19 (6): 328–36. PMID20504242. doi:10.3109/08037051.2010.488052
He, FJ; MacGregor GA (Junho de 2009). «A comprehensive review on salt and health and current experience of worldwide salt reduction programmes». Journal of Human Hypertension (em inglês). 23 (6): 363–84. PMID19110538. doi:10.1038/jhh.2008.144
Dickinson, HO; Mason JM; Nicolson DJ; Campbell F; et al. (Fevereiro de 2006). «Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials.». J Hypertens. (em inglês). 24 (2): 215-33. PMID16508562
Lawlor, Debbie A; Smith, GD (Maio de 2005). «Early life determinants of adult blood pressure.». Current Opinion in Nephrology & Hypertension (em inglês). 14 (3): 259–64. PMID15821420. doi:10.1097/01.mnh.0000165893.13620.2b
Grossman, Ehud; Messerli FH (Janeiro de 2012). «Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension». Am. J. Med. (em inglês). 125 (1): 14–22. PMID22195528. doi:10.1016/j.amjmed.2011.05.024
Conway J (abril de 1984). «Hemodynamic aspects of essential hypertension in humans». Physiol. Rev. 64 (2): 617–60. PMID6369352
Palatini, Paolo; Julius S (Junho de 2009). «The role of cardiac autonomic function in hypertension and cardiovascular disease.». Current Hypertension Reports (em inglês). 11 (3): 199-205. PMID19442329. doi:10.1007/s11906-009-0035-4
Andersson OK, Lingman M, Himmelmann A, Sivertsson R, Widgren BR (2004). «Prediction of future hypertension by casual blood pressure or invasive hemodynamics? A 30-year follow-up study». Blood Press. 13 (6): 350–4. PMID15771219. doi:10.1080/08037050410004819 !CS1 manut: Nomes múltiplos: lista de autores (link)
Folkow B (abril de 1982). «Physiological aspects of primary hypertension». Physiol. Rev. 62 (2): 347–504. PMID6461865
Chobanian AV (agosto de 2007). «Clinical practice. Isolated systolic hypertension in the elderly». N. Engl. J. Med. 357 (8): 789–96. PMID17715411. doi:10.1056/NEJMcp071137
Whelton, PK; He J, Appel LJ, Cutler JA; et al. (Outubro de 2002). «Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program». JAMA (em inglês). 288 (15): 1882-8. PMID12377087. doi:10.1001/jama.288.15.1882 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Siebenhofer, Andrea; Jeitler K, Berghold A, Waltering A; et al. (7 de setembro de 2011). «Long-term effects of weight-reducing diets in hypertensive patients». Cochrane Database Syst Rev. (em inglês) (9): CD008274. PMID21901719. doi:10.1002/14651858.CD008274.pub !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Blumenthal, JA; Babyak MA; Hinderliter A; Watkins LL; et al. (Janeiro de 2010). «Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study.». Arch Intern Med (em inglês). 170 (2): 126-35. PMID20101007. doi:10.1001/archinternmed.2009.470
Greenhalgh, J; Dickson R, Dundar Y (Outubro de 2009). «The effects of biofeedback for the treatment of essential hypertension: a systematic review.». Health Technol Assess. (em inglês). 13 (46): 1-104. PMID19822104. doi:10.3310/hta13460
Ospina, MB; Bond K, Karkhaneh M, Tjosvold L; et al. (Junho de 2007). «Meditation practices for health: state of the research.». Evidence Reports/Technology Assessments (em inglês) (155): 1–263. PMID17764203 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
He, Feng J; MacGregor GA (2004). «Effect of longer-term modest salt reduction on blood pressure». Cochrane Database Syst Rev. (em inglês) (3): CD004937. PMID15266549. doi:10.1002/14651858.CD004937
Musini, Vijaya M; Tejani AM, Bassett K, Wright JM (2009). «Pharmacotherapy for hypertension in the elderly». Cochrane Database Syst Rev (em inglês) (4): CD000028. PMID19821263. doi:10.1002/14651858.CD000028.pub2 !CS1 manut: Nomes múltiplos: lista de autores (link)
Calhoun DA; Jones D; Textor S; et al. (Junho de 2008). «Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research». Hypertension. 51 (6): 1403–19. PMID18391085. doi:10.1161/HYPERTENSIONAHA.108.189141
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (Dezembro de 2002). «Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies». Lancet. 360 (9349): 1903–13. PMID12493255. doi:10.1016/S0140-6736(02)11911-8 !CS1 manut: Nomes múltiplos: lista de autores (link)
Singer DR, Kite A (Junho de 2008). «Management of hypertension in peripheral arterial disease: does the choice of drugs matter?». European Journal of Vascular and Endovascular Surgery. 35 (6): 701–8. PMID18375152. doi:10.1016/j.ejvs.2008.01.007
Zeng C, Villar VA, Yu P, Zhou L, Jose PA (abril de 2009). «Reactive oxygen species and dopamine receptor function in essential hypertension». Clinical and Experimental Hypertension. 31 (2): 156–78. PMID19330604. doi:10.1080/10641960802621283 !CS1 manut: Nomes múltiplos: lista de autores (link)
Kearney, PM; Whelton M, Reynolds K, Muntner P; et al. (Janeiro de 2005). «Global burden of hypertension: analysis of worldwide data». Lancet (em inglês). 365 (9455): 217–23. PMID15652604. doi:10.1016/S0140-6736(05)17741-1 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Alcocer, L; Cueto L (Junho de 2008). «Hypertension, a health economics perspective». Therapeutic Advances in Cardiovascular Disease (em inglês). 2 (3): 147-55. PMID19124418. doi:10.1177/1753944708090572
Elliott, William J (Outubro de 2003). «The Economic Impact of Hypertension». The Journal of Clinical Hypertension (em inglês). 5 (4): 3-13. PMID12826765. doi:10.1111/j.1524-6175.2003.02463.x
Coca, A (2008). «Economic benefits of treating high-risk hypertension with angiotensin II receptor antagonists (blockers)». Clinical Drug Investigation (em inglês). 28 (4): 211-20. PMID18345711. doi:10.2165/00044011-200828040-00002
National Clinical Guidance Centre (Agosto de 2011). «7 Diagnosis of Hypertension, 7.5 Link from evidence to recommendations». Hypertension (NICE CG 127)(PDF). [S.l.]: National Institute for Health and Clinical Excellence. p. 102. Consultado em 22 de dezembro de 2012. Arquivado do original(PDF) em 23 de julho de 2013